JP2015510928A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015510928A5 JP2015510928A5 JP2015501754A JP2015501754A JP2015510928A5 JP 2015510928 A5 JP2015510928 A5 JP 2015510928A5 JP 2015501754 A JP2015501754 A JP 2015501754A JP 2015501754 A JP2015501754 A JP 2015501754A JP 2015510928 A5 JP2015510928 A5 JP 2015510928A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formulated
- analgesics
- release
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 229940035676 analgesics Drugs 0.000 claims 8
- 239000000730 antalgic agent Substances 0.000 claims 8
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 7
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 claims 7
- 229960001475 zolpidem Drugs 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 6
- 230000003111 delayed effect Effects 0.000 claims 5
- 238000013265 extended release Methods 0.000 claims 5
- 229940124538 antidiuretic agent Drugs 0.000 claims 3
- 239000003160 antidiuretic agent Substances 0.000 claims 3
- 229940124575 antispasmodic agent Drugs 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 239000000812 cholinergic antagonist Substances 0.000 claims 3
- 239000003149 muscarinic antagonist Substances 0.000 claims 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
- 108030001720 Bontoxilysin Proteins 0.000 claims 2
- 229940053031 botulinum toxin Drugs 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 230000027939 micturition Effects 0.000 claims 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 229960004270 nabumetone Drugs 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 229960003940 naproxen sodium Drugs 0.000 claims 1
- CDBRNDSHEYLDJV-FVGYRXGTSA-M naproxen sodium Chemical compound [Na+].C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CDBRNDSHEYLDJV-FVGYRXGTSA-M 0.000 claims 1
- 229960005489 paracetamol Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/424,000 US8236857B2 (en) | 2010-07-08 | 2012-03-19 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US13/424,000 | 2012-03-19 | ||
| US13/487,348 US20120244221A1 (en) | 2010-07-08 | 2012-06-04 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US13/487,348 | 2012-06-04 | ||
| PCT/US2013/030901 WO2013142197A1 (en) | 2012-03-19 | 2013-03-13 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017179685A Division JP2018024693A (ja) | 2012-03-19 | 2017-09-20 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015510928A JP2015510928A (ja) | 2015-04-13 |
| JP2015510928A5 true JP2015510928A5 (enrdf_load_stackoverflow) | 2016-03-24 |
Family
ID=49223209
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501754A Pending JP2015510928A (ja) | 2012-03-19 | 2013-03-13 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
| JP2015501785A Pending JP2015510936A (ja) | 2012-03-19 | 2013-03-14 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2016092868A Pending JP2016172752A (ja) | 2012-03-19 | 2016-05-04 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2017179685A Pending JP2018024693A (ja) | 2012-03-19 | 2017-09-20 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
| JP2018093416A Pending JP2018138602A (ja) | 2012-03-19 | 2018-05-15 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501785A Pending JP2015510936A (ja) | 2012-03-19 | 2013-03-14 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2016092868A Pending JP2016172752A (ja) | 2012-03-19 | 2016-05-04 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
| JP2017179685A Pending JP2018024693A (ja) | 2012-03-19 | 2017-09-20 | 排尿頻度を減少させるための延長放出製剤およびその使用方法 |
| JP2018093416A Pending JP2018138602A (ja) | 2012-03-19 | 2018-05-15 | 排尿頻度を減少させるための延長放出製剤およびその使用の方法 |
Country Status (15)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| JP2016525548A (ja) | 2013-07-23 | 2016-08-25 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉ� | Β−３アドレナリン受容体刺激薬と組み合わせたデスモプレシンを含む方法及び組成物 |
| RU2016152226A (ru) * | 2014-06-06 | 2018-07-09 | УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Фармацевтический состав для уменьшения частоты мочеиспускания и способ его применения |
| KR101809908B1 (ko) * | 2014-07-21 | 2018-01-25 | 주식회사 종근당 | 5-알파환원효소억제제를 포함하는 조성물 |
| AU2015349811B2 (en) * | 2014-11-20 | 2021-05-06 | Acerus Pharmaceuticals USA, LLC | Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist |
| AU2016331871A1 (en) * | 2015-09-30 | 2018-05-17 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
| CN108430465A (zh) * | 2015-09-30 | 2018-08-21 | 韦尔斯利医药有限公司 | 用于缓解尿频的组合物、其制造方法和用途 |
| CN105238124B (zh) * | 2015-11-16 | 2018-02-09 | 太仓东能环保设备有限公司 | 一种抗菌腻子粉 |
| JP6294924B2 (ja) | 2016-09-05 | 2018-03-14 | 株式会社Ｓｕｂａｒｕ | 車両の走行制御装置 |
| JP2019031556A (ja) * | 2018-10-31 | 2019-02-28 | ウェルズリー ファーマスーティカルズ、エルエルシー | 排尿頻度を減少させるための医薬製剤およびその使用の方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1053752A1 (en) * | 1998-02-10 | 2000-11-22 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparations with controlled release |
| US20020102309A1 (en) * | 1999-09-14 | 2002-08-01 | Jane C. I. Hirsh | Controlled release formulation for administration of an anti-inflammatory naphthalene derivative |
| DE10116978A1 (de) * | 2001-04-05 | 2002-10-10 | Merck Patent Gmbh | Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase |
| US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| CA2475374A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| AU2003242166A1 (en) * | 2002-06-07 | 2003-12-22 | Astellas Pharma Inc. | Therapeutic agent for overactive bladder |
| US20040054008A1 (en) * | 2002-09-13 | 2004-03-18 | Tohru Araki | Medicament for treatment of nocturia |
| US20040198822A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmacueticals, Inc. | Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators |
| CN1758904A (zh) * | 2003-03-21 | 2006-04-12 | 麦克内尔-Ppc股份有限公司 | 非甾体抗炎药物的给药方案 |
| EP1627876A1 (en) * | 2004-08-20 | 2006-02-22 | Ferring B.V. | Heterocyclic condensed compounds useful as antidiuretic agents |
| EP2400300A1 (en) * | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
| AU2006259262A1 (en) * | 2005-06-17 | 2006-12-28 | Dynamis Therapeutics, Inc. | Treatment of inflammatory conditions |
| US20080085314A1 (en) * | 2005-07-29 | 2008-04-10 | Shalaby Shalaby W | Solid oral formulations for combination therapy |
| DE602006021444D1 (de) * | 2005-09-02 | 2011-06-01 | Theravida Inc | Therapie zur behandlung der überaktiven blase |
| WO2010138441A1 (en) * | 2009-05-28 | 2010-12-02 | Aptapharma, Inc. | Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen |
| GB201003731D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
| US20120244221A1 (en) * | 2010-07-08 | 2012-09-27 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US20120010294A1 (en) * | 2010-07-08 | 2012-01-12 | Dill David A | Compositions and methods for the inhibition of muscle contraction |
-
2013
- 2013-03-13 CA CA2866853A patent/CA2866853A1/en not_active Abandoned
- 2013-03-13 KR KR1020147029163A patent/KR20140134333A/ko not_active Ceased
- 2013-03-13 JP JP2015501754A patent/JP2015510928A/ja active Pending
- 2013-03-13 NZ NZ718163A patent/NZ718163A/en not_active IP Right Cessation
- 2013-03-13 MY MYPI2014702434A patent/MY174090A/en unknown
- 2013-03-13 EP EP13763764.1A patent/EP2827852A4/en not_active Withdrawn
- 2013-03-13 CN CN201710373440.5A patent/CN107157991A/zh active Pending
- 2013-03-13 SG SG11201500408VA patent/SG11201500408VA/en unknown
- 2013-03-13 CN CN201380015062.3A patent/CN104302284A/zh active Pending
- 2013-03-13 WO PCT/US2013/030901 patent/WO2013142197A1/en active Application Filing
- 2013-03-13 BR BR112014020271A patent/BR112014020271A8/pt not_active Application Discontinuation
- 2013-03-13 RU RU2014142025A patent/RU2669565C2/ru not_active IP Right Cessation
- 2013-03-13 NZ NZ630471A patent/NZ630471A/en not_active IP Right Cessation
- 2013-03-13 NZ NZ714288A patent/NZ714288A/en not_active IP Right Cessation
- 2013-03-13 AU AU2013235518A patent/AU2013235518B2/en not_active Ceased
- 2013-03-13 NZ NZ712594A patent/NZ712594A/en not_active IP Right Cessation
- 2013-03-13 MX MX2014011128A patent/MX2014011128A/es unknown
- 2013-03-14 MX MX2014011129A patent/MX2014011129A/es unknown
- 2013-03-14 KR KR20147024604A patent/KR20140134284A/ko not_active Ceased
- 2013-03-14 KR KR1020187038194A patent/KR20190003840A/ko not_active Ceased
- 2013-03-14 CA CA2866755A patent/CA2866755A1/en not_active Abandoned
- 2013-03-14 RU RU2016133305A patent/RU2016133305A/ru not_active Application Discontinuation
- 2013-03-14 CN CN201380015025.2A patent/CN104321056A/zh active Pending
- 2013-03-14 NZ NZ628079A patent/NZ628079A/en not_active IP Right Cessation
- 2013-03-14 CN CN201711086139.2A patent/CN107789626A/zh active Pending
- 2013-03-14 NZ NZ714662A patent/NZ714662A/en not_active IP Right Cessation
- 2013-03-14 SG SG11201500409SA patent/SG11201500409SA/en unknown
- 2013-03-14 AU AU2013235507A patent/AU2013235507B2/en not_active Ceased
- 2013-03-14 JP JP2015501785A patent/JP2015510936A/ja active Pending
- 2013-03-14 RU RU2014142066/15A patent/RU2599017C2/ru not_active IP Right Cessation
- 2013-03-14 WO PCT/US2013/031617 patent/WO2013142274A1/en active Application Filing
- 2013-03-14 MY MYPI2014702174A patent/MY175764A/en unknown
- 2013-03-14 HK HK15105034.0A patent/HK1204553A1/xx unknown
- 2013-03-14 KR KR1020177002422A patent/KR20170015537A/ko not_active Ceased
- 2013-03-14 BR BR112014020113A patent/BR112014020113A8/pt not_active Application Discontinuation
- 2013-03-14 EP EP13763665.0A patent/EP2827851A4/en not_active Withdrawn
-
2014
- 2014-08-11 ZA ZA2014/05862A patent/ZA201405862B/en unknown
- 2014-08-21 ZA ZA2014/06146A patent/ZA201406146B/en unknown
- 2014-09-17 MX MX2019008817A patent/MX2019008817A/es unknown
-
2015
- 2015-05-27 HK HK18110965.0A patent/HK1251469A1/zh unknown
-
2016
- 2016-05-04 JP JP2016092868A patent/JP2016172752A/ja active Pending
-
2017
- 2017-05-11 AU AU2017203139A patent/AU2017203139B2/en not_active Ceased
- 2017-05-15 AU AU2017203246A patent/AU2017203246B2/en not_active Ceased
- 2017-09-20 JP JP2017179685A patent/JP2018024693A/ja active Pending
-
2018
- 2018-03-10 HK HK18103371.3A patent/HK1243921A1/zh unknown
- 2018-05-15 JP JP2018093416A patent/JP2018138602A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015510928A5 (enrdf_load_stackoverflow) | ||
| RU2014142025A (ru) | Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| JP2015523407A5 (enrdf_load_stackoverflow) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| AR122580A2 (es) | Forma de dosificación de doxilamina y piridoxina y/o sus metabolitos o sales | |
| JP2012255026A5 (enrdf_load_stackoverflow) | ||
| CL2014002754A1 (es) | Forma de dosis de liberación controlada solida que comprende un nucleo con una primera porcion de un analgesico opioide y una cubierta que encierra el nucleo y comprende una segunda porcion del analgesico opioide; metodo de preparacion; uso en el tratamiento del dolor. (divisional de solicitud n°1450-2014). | |
| JP2008505857A5 (enrdf_load_stackoverflow) | ||
| JP2013509429A5 (enrdf_load_stackoverflow) | ||
| JP2014521735A5 (enrdf_load_stackoverflow) | ||
| JP2012193216A5 (enrdf_load_stackoverflow) | ||
| JP2015038135A5 (enrdf_load_stackoverflow) | ||
| BR112012024019A2 (pt) | forma de dosagem de liberação controlada, e, método para liberar uma droga | |
| JP2013231087A5 (enrdf_load_stackoverflow) | ||
| EA201071204A1 (ru) | Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности | |
| CL2014002935A1 (es) | Metodo para tratar un paciente humano con esclerosis multiple con laquinimod, en una dosis diaria de alrededor de 1,2mg; un aforma de dosificacion unitaria oral de 1,2 mg de laquinimod y un portador | |
| UA117260C2 (uk) | Лікарський препарат з відстроченим вивільненням | |
| ECSP11011289A (es) | Formulaciones galénicas de compuestos orgánicos | |
| WO2014114255A3 (zh) | 一种定位速释生物粘附剂及应用 | |
| WO2015038552A3 (en) | Aspirin formulation for increased efficacy | |
| JP2013166781A5 (enrdf_load_stackoverflow) | ||
| WO2014107730A3 (en) | Use of fatty acid niacin conjugates for treating diseases | |
| JP2015522658A5 (enrdf_load_stackoverflow) | ||
| PH12015500165A1 (en) | Formulations and methods of manufacturing formulations for use in colonic evacuation |